GI
ASND icon

GAMMA Investing’s Ascendis Pharma A/S ASND Stock Holding History

GAMMA Investing’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
1,037
+80
+8% +$18.7K 0.01% 1030
2026
Q1 		$219K Buy
957
+107
+13% +$24K 0.01% 1048
2025
Q4 		$181K Buy
850
+115
+16% +$23.8K 0.01% 1111
2025
Q3 		$146K Buy
735
+97
+15% +$18.1K 0.01% 1198
2025
Q2 		$110K Buy
638
+51
+9% +$8.31K 0.01% 1367
2025
Q1 		$91.5K Buy
587
+4
+0.7% +$571 0.01% 1334
2024
Q4 		$80.3K Buy
583
+214
+58% +$28.1K 0.01% 1280
2024
Q3 		$55.1K Buy
369
+64
+21% +$8.64K 0.01% 1421
2024
Q2 		$41.6K Buy
305
+7
+2% +$952 0.01% 1323
2024
Q1 		$45K Buy
298
+102
+52% +$14.6K 0.01% 1112
2023
Q4 		$25.5K Buy
+196
New +$19.5K 0.01% 1333

Other funds holding ASND

AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HJIM
Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return